Your browser doesn't support javascript.
loading
Achievement of complete remission predicts outcome of allogeneic haematopoietic stem cell transplantation in patients with chronic myelomonocytic leukaemia. A study of the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation.
Symeonidis, Argiris; van Biezen, Anja; de Wreede, Liesbeth; Piciocchi, Alfonso; Finke, Juergen; Beelen, Dietrich; Bornhäuser, Martin; Cornelissen, Jan; Volin, Liisa; Mufti, Ghulam; Chalandon, Yves; Ganser, Arnold; Bruno, Benedetto; Niederwieser, Dietger; Kobbe, Guido; Schwerdtfeger, Rainer; de Witte, Theo; Robin, Marie; Kröger, Nicolaus.
Affiliation
  • Symeonidis A; Haematology Division, Department of Internal Medicine, University of Patras Medical School, Patras, Greece.
  • van Biezen A; Department of Medical Statistics & Bioinformatics, Leiden University Medical Centre, Leiden, the Netherlands.
  • de Wreede L; Department of Medical Statistics & Bioinformatics, Leiden University Medical Centre, Leiden, the Netherlands.
  • Piciocchi A; GIMEMA Data Centre, Rome, Italy.
  • Finke J; Department of Medicine, Haematology, Oncology, University of Freiburg, Freiburg, Germany.
  • Beelen D; Department of Bone Marrow Transplantation, University Hospital, Essen, Germany.
  • Bornhäuser M; Medizinische Klinik und Poliklinik I, Universitätsklinikum Technische Universität Dresden, Dresden, Germany.
  • Cornelissen J; Erasmus MC-Daniel den Hoed Cancer Centre, Rotterdam, the Netherlands.
  • Volin L; Stem Cell Transplantation Unit, Comprehensive Cancer Centre, Helsinki University Hospital, Helsinki, Finland.
  • Mufti G; Department of Haematological Medicine, GKT School of Medicine, London, UK.
  • Chalandon Y; Département des Spécialités de Médecine Service d'Hématologie, Hôpitaux Universitaires de Genève, and Faculty of Medicine, University of Geneva, Geneva, Switzerland.
  • Ganser A; Department of Haematology, Haemostasis and Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany.
  • Bruno B; Division of Haematology, Città della Salute e della Scienza di Torino, Torino, Italy.
  • Niederwieser D; Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy.
  • Kobbe G; Division of Haematology, Oncology and Haemostasiology, University of Leipzig, Leipzig, Germany.
  • Schwerdtfeger R; Department for Haematology, Oncology and Clinical Immunology, University Hospital Dusseldorf, Heinrich Heine University, Dusseldorf, Germany.
  • de Witte T; Deutsche Klinik fur Diagnostik, KMT Zentrum, Wiesbaden, Germany.
  • Robin M; Department of Tumourimmunology, Radboud University Medical Centre, Nijmegen, the Netherlands.
  • Kröger N; Department of Haematology and BMT, Hopital Saint Louis, Paris, France.
Br J Haematol ; 171(2): 239-246, 2015 Oct.
Article de En | MEDLINE | ID: mdl-26212516
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Prognostic_studies / Risk_factors_studies Langue: En Journal: Br J Haematol Année: 2015 Type de document: Article Pays d'affiliation: Grèce Pays de publication: Royaume-Uni
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Prognostic_studies / Risk_factors_studies Langue: En Journal: Br J Haematol Année: 2015 Type de document: Article Pays d'affiliation: Grèce Pays de publication: Royaume-Uni